ARID1B and breast carcinoma: As shown in Figure 2A, we observed a significant upregulation of ARID1B in all types of breast cancer cells when compared to the normal breast epithelial (184‐B5) or non‐tumorigenic breast epithelial cell lines (MCF10A and MCF12A).